000			01679 a2200469 4500
005			20250512030626.0
264		0	_c19850712
008			198507s 0 0 eng d
022			_a0008-543X
024	7		_a10.1002/1097-0142(19850615)55:12<2753::aid-cncr2820551204>3.0.co;2-q _2doi
040			_aNLM _beng _cNLM
100	1		_aKlefström, P
245	0	0	_aLevamisole in the treatment of stage II breast cancer. Five-year follow-up of a randomized double-blind study. _h[electronic resource]
260			_bCancer _cJun 1985
300			_a2753-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aActuarial Analysis
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCarcinoma _xdrug therapy
650	0	4	_aCarcinoma, Intraductal, Noninfiltrating _xdrug therapy
650	0	4	_aCombined Modality Therapy
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHematologic Diseases _xchemically induced
650	0	4	_aHumans
650	0	4	_aLevamisole _xadverse effects
650	0	4	_aMenopause
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Recurrence, Local
650	0	4	_aNeoplasm Staging
650	0	4	_aRandom Allocation
700	1		_aHolsti, P
700	1		_aGröhn, P
700	1		_aHeinonen, E
700	1		_aHolsti, L
773	0		_tCancer _gvol. 55 _gno. 12 _gp. 2753-7
856	4	0	_uhttps://doi.org/10.1002/1097-0142(19850615)55:12<2753::aid-cncr2820551204>3.0.co;2-q _zAvailable from publisher's website
999			_c2992639 _d2992639